Johnson & Johnson's stock offers value with promising MedTech growth, raised guidance, strong dividends, and bullish ...

Down in Bradenton, Fred "Jigg" Johnson is rising through the boxing ranks, and using his mental game to do so.

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

Johnson & Johnson announced Friday it will split itself into two publicly traded companies, separating its lucrative pharmaceutical and medical devices divisions from the consumer products ...

The big appeal of Johnson & Johnson over the years has been that it's a relatively safe stock to own, and it also offers an attractive dividend yield of 2.8% -- the S&P 500 average is just over 1.5%.

Johnson & Johnson’s Covid-19 single-shot vaccine was shown to be 66% effective in preventing moderate and severe disease in a global Phase 3 trial, but 85% effective against severe disease, the ...

Johnson & Johnson plans to spin off its consumer health division that sells Listerine and Baby Powder to focus on pharmaceuticals and medical devices in the biggest shake-up in the U.S. company's ...

Johnson & Johnson spun off liabilities — including roughly 38,000 lawsuits — linked to claims of asbestos contamination in its baby powder to a new firm, which then declared bankruptcy.